Advertisement

Pharmacy

Three drugmakers — Jazz Pharmaceuticals, Lundbeck and Alexion Pharmaceuticals — have agreed to pay $122.6 million to resolve allegations of violating the Anti-Kickback Statute by illegally using copay assistance programs.

After Scott Gottlieb, MD, steps down as commissioner of the FDA April 5, he will head back to the American Enterprise Institute to tackle the rising cost of prescription drugs, according to The Washington Post.

Advertisement

Pharmaceutical Associates, a drugmaker based in Greenville, S.C., raised the price of its generic version of Prozac by 568 percent, according to The Financial Times.

Several drugs are slated to make their debuts in 2019, but only seven are projected to achieve blockbuster status within four years, according to a new report from analytic firm Cortellis.

Advertisement